Antibodies to double stranded DNA are found in 60-70% of patients with active, untreated systemic lupus erythematosus (SLE) and, when present in high titre, show relatively good specificity for the disease. Although the importance of these antibodies is not quite as clearcut as once thought,2 their detection is now an established routine laboratory procedure and of undoubted value in assessing a patient suspected of having SLE. A variety of techniques are used but only the most commonly used methods will be described here: for a fuller account, the reader is referred to Stollar.3 Tests which detect precipitating antibodies to extractable nuclear antigens are being more widely used in the assessment of patients with connective tissue diseases such as SLE, Sjogren's syndrome, polymyositis and systemic sclerosis. Antibodies can be detected to a large number of saline extractable constituents of mammalian cells.4 To date the reactions found most commonly in CTD, and the best characterised, concern antibodies to U 1 RNP, Sm, Ro(SSA), La(SSB), Jo-I and Scl-70. These are highly conserved nuclear or cytoplasmic macromolecules present in a wide range of animal tissues, and the antigenic determinants are expressed in polypeptide components. Jo Anti-Ro is also strongly associated with the development of neonatal lupus and isolated complete heart block. These antibodies identify women with connective tissue diseases most at risk of having babies with these complications. Not all women with antibodies to Ro have affected babies, however, and the degree of risk is not yet known.
Each antibody specificity is found in small subsets of patients with CTD and so to be of help to the clinician the laboratory should be able to detect antibodies to a spectrum of extrac- dard sera and of the diluted unknown sera are aliquoted in duplicate into the tubes provided, which are covered with aluminium foil and incubated in a water bath at 56°C for 30 minutes. Heat treatment is used to inactivate Clq, which can bind DNA, so eliminating any non-specific binding proteins. After the tubes are removed from the water bath 50jul of the radiolabelled DNA is added, the tubes vortex mixed for five seconds, covered, and incubated in a 37°C water bath for one hour. The tubes are then removed and kept at 4°C for 20-24 hours.
The ammonium sulphate (100 1l) is added to the tubes which are then vortex mixed and centrifuged for 15 minutes at 1000g at room temperature. The supernatant is aspirated off using a Pasteur pipette attached to a suction pump, carefully avoiding the removal of any precipitate. The radioactivity associated with the precipitates is then counted in a gamma counter (60 seconds counting time). A standard curve is constructed by plotting the counts against anti-DNA antibody standards, and the values for unknown sera are read off the graph. It may be necessary to dilute the sera, in which case the values are calculated by multiplying the read-off result by the appropriate dilution factor.
As part of their quality assurance programme, Amersham International have informed us that they regularly test interbatch and intrabatch variations. They ensure that standard samples of 10 U/ml, 20 U/ml, and 50 U/ml vary by less than 6 U, 8 The Ouchterlony technique is one of the simplest and most informative methods. In this procedure antigen and antibody are allowed to diffuse towards each other in a buffered agarose gel and a line of precipitation is formed where the two reactants meet. The precipitate is soluble in excess antigen or antibody, so that a sharp line is produced at equivalence, its relative position being determined by: (i) the concentration of the antigen and antibody in the agar; and (ii) by the molecular weight of the reactants. For these reasons, some sera with high titre antibodies need to be diluted to optimise the line of precipitation. This technique has the advantage that several antigens or sera can be compared around a single well of antibody or antigen. 2 Interpretation: identification of antibody specificity by the pattern of reactions with extracts treated with various enzymes is not recommended. It should be achieved using prototype sera placed in wells adjacent to the positive test sera (fig 1) . 3 Techniques such as passive haemagglutination have been used to detect antibodies to extractable nuclear antigens10 but these methods are not recommended unless purified antigen preparations are available. Using immunoaffinity purified antigen, a number of sensitive assays such as ELISA have been developed and will become available in the future. 4 Certain antibodies tend to occur in the same serum. Anti-La-for example, is only very rarely found in the absence of anti-Ro. Antibodies to Ro are accompanied by anti-La in about 50% of cases. Similarly anti-Sm very often accompanies anti-Ul RNP. (fig 2) . This can be facilitated by reducing the vertical distance between the wells to I mm, staggering the serum and tissue extract wells or by cutting a trough for the extract. 4 0-01% sodium azide can be added to the agarose to retard bacterial growth but this may necessitate changes in the conditions of electrophoresis because of the charge changes relative to the sodium azide. 5 We use CIE as a screening test and confirm the identity of precipitins by the Ouchterlony technique. Other laboratories, however, depend entirely on CIE. 6 
